Subsection 1.6.1—4(1) Item [34] replaces Schedule’ with table to section S27—4’, to correct a referencing ‘the ‘the error. Subsection 1.6.1—4(2) Item [35] replaces Schedule’ with table to section S27—4’, to correct a referencing ‘the ‘the error. Section 2.2.1—1 Item [36] replaces the heading to section 2.2.1—1 with to correct a transcription ‘Name’, error. Section 2.6.2—3 Item [37] repeals the Note at the end of section 2.6.2—3, to delete an unnecessary Note. Section 2.8.1—1 Item [38] replaces Sugars and honey’ with Sugar and sugar products’, to correct a ‘— ‘— transcription error. Paragraph 2.9.2—8(1)(b) Item [39] replaces than of 3 g’ with than 3 g’, to include in the P1025 Code the ‘more ‘more variation made in P1033. Section 2.9.3—2 Item [40] deletes a note that had been retained in the P1025 Code in error. Subparagraph 2.9.3—8(3)(a) Item [41] corrects a reference, using the terminology of the P1025 Code. Paragraph 2.9.4—5(2)(a) Item [42] inserts after to correct a typographical error. ‘as’ ‘(expressed’, Paragraph 2.9.4—6(2)(a) Item [43] inserts *ESADDI’ to correct an omission. ‘or ‘*RDI’, Paragraph 2.9.5—3(a) Item [44] deletes Standard 1.1A.2 (transitional standard for health claims)’, to delete an ‘or unnecessary reference. Schedule 3 Subparagraph S3—27(2)(b)(ii) Item [45] replaces with to correct a typographical error. ‘campsteranol’ ‘campestanol’,
Subsection 1.6.1—4(1) Item [34] replaces ‘the Schedule’ with ‘the table to section S27—4’, to correct a referencing error. Subsection 1.6.1—4(2) Item [35] replaces ‘the Schedule’ with ‘the table to section S27—4’, to correct a referencing error. Section 2.2.1—1 Item [36] replaces the heading to section 2.2.1—1 with ‘Name’, to correct a transcription error. Section 2.6.2—3 Item [37] repeals the Note at the end of section 2.6.2—3, to delete an unnecessary Note. Section 2.8.1—1 Item [38] replaces ‘— Sugars and honey’ with ‘— Sugar and sugar products’, to correct a transcription error. Paragraph 2.9.2—8(1)(b) Item [39] replaces ‘more than of 3 g’ with ‘more than 3 g’, to include in the P1025 Code the variation made in P1033. Section 2.9.3—2 Item [40] deletes a note that had been retained in the P1025 Code in error. Subparagraph 2.9.3—8(3)(a) Item [41] corrects a reference, using the terminology of the P1025 Code. Paragraph 2.9.4—5(2)(a) Item [42] inserts ‘as’ after ‘(expressed’, to correct a typographical error. Paragraph 2.9.4—6(2)(a) Item [43] inserts ‘or *ESADDI’ ‘*RDI’, to correct an omission. Paragraph 2.9.5—3(a) Item [44] deletes ‘or Standard 1.1A.2 (transitional standard for health claims)’, to delete an unnecessary reference. Schedule 3 Subparagraph S3—27(2)(b)(ii) Item [45] replaces ‘campsteranol’ with ‘campestanol’, to correct a typographical error.